BioCryst Pharmaceuticals, Inc. Net Promoter Score 2020 Benchmarks

Estimated Net Promoter Score is

12

BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals. The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1 pandemic.

Quick facts about BioCryst Pharmaceuticals, Inc.

Key people

Jon P. Stonehouse , President and Chief Executive Officer Thomas Staab II, Chief Financial Officer

Headquarters

Durham, North Carolina, USA

Operating income

US$-33.9M (FY 2012)

Net income

US$-39.1M (FY 2012)

Revenue

US$26.3M (FY 2012)

What is Net Promoter Score?

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.

Learn more about NPS

Is BioCryst Pharmaceuticals, Inc.'s estimated NPS of 12 considered to be good?

Yes, it is.

Net Promoter Score is a number from -100 from 100.

Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.

The industry average for Health Care / Biotechnology: Biological Products (No Diagnostic Substances) is 0.

Browse NPS benchmarks

How to understand the NPS benchmarks

The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.

Consider an example: If BioCryst Pharmaceuticals, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.

On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.

Therefore, comparing the NPS score of BioCryst Pharmaceuticals, Inc. with your own without any further context is not that useful.

What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.

What is Customer.guru? Why is useful?

After successfully using Net Promoter Score for our own e-commerce projects,
 we have decided to let anyone benefit from what we've learned.



We have founded Customer.guru in 2016 to help e-shops, SaaS services and startups better understand their customers, improve their services and increase their revenues.

Customer.guru is an easy-to-setup tool for tracking segmented customer satisfaction using Net Promoter Score.

Learn more

Other companies with Net Promoter Score similar to BioCryst Pharmaceuticals, Inc.

Company Industry Score
DirecTV Telecommunications / Cable/TV service 12
MTV Consumer Brands / Entertainment 12
AXA Financial Services / Banking 12
Showtime Consumer Brands / Entertainment 11
KPN Telecommunications / Wireless Carrier 11
Blockbuster on Demand Consumer Brands / Entertainment 11
Google Consumer Brands / Internet 11
Netflix Consumer Brands / Entertainment 13
TD Bank Financial Services / Banking 10
Liberty Mutual Insurance / Health and Life Insurance 14

We have estimated the Net Promoter Score of BioCryst Pharmaceuticals, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.

Do you think this information is incorrect? Report incorrect information. Do you have more accurate data? Submit NPS score.